Optovue Announces Bill Jackson Joining Team as VP of Regulatory & Quality

Share Article

Experienced senior level regulatory & quality assurance executive, Bill Jackson joins Optovue management team

Optovue, Inc. announces that Bill Jackson has joined the company as VP of Regulatory and Quality Assurance. Bill is a senior level regulatory, clinical and quality assurance executive with over 30 years of regulatory experience and 25 years in Quality for class II and III medical device manufacturers. Bill has lead submissions to over 75 countries and was on the committee that wrote the medical directives in Europe.

In addition to running a successful consulting practice for over a decade, Bill has previously held VP level positions at MiMedx Group, and TranS1. Bill started his career in the hospital/research environment followed by industry experience at Intermedics Pacemakers, Neuromed, and St. Jude Medical. Bill has authored or participated in several hundred 510(K) submissions and used this experience to teach a graduate level course on the 510(K) submittal process at the University of St. Thomas. Bill holds a BA in Zoology from Concordia College and an MBA from the University of Minnesota.

About RTVue®, iVue® and iStandâ„¢
RTVue was the first FDA-cleared Spectral-Domain OCT launched in the United States, and also the first OCT cleared by the U.S. Food and Drug Administration for both corneal and retinal imaging. The iVue is the compact version of the RTVue OCT, offering the same scanning speed and resolution as the larger system, that includes scanning and reports for retina, retina nerve fiber and cornea assessment by the clinician. iStand is a rolling floor stand option for iVue. When mounted to iStand, patients are able to be scanned in various positions including the supine position.

About Optovue® (http://www.optovue.com)
Optovue Inc. is a privately-held ophthalmic device company dedicated to working with eye care professionals and clinical researchers to lead the commercialization of new imaging modalities that improve diagnosis and therapy of ocular disease. Optovue has achieved widespread market success through a combination of unique data analysis design, a reputation for excellent customer service, and rapid innovation of its technology in response to physician feedback. The company is headquartered in Fremont, CA, with operations in Carlsbad, CA and European operations in Dossenheim, Germany.

For more information, visit http://www.optovue.com.


Paul Kealey
Sr. Vice President of Marketing
510-623-8868 x105

Bill Jackson
Vice President of Regulatory & Quality Assurance
510-623-8868 x205

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Paul Kealey

Bill Jackson
Visit website